MiR-101 targets USP22 to inhibit the tumorigenesis of papillary thyroid carcinoma.
Zhao H, Tang H, Huang Q, Qiu B, Liu X, Fan D, Gong L, Guo H, Chen C, Lei S, Yang L, Lu J, Bao G.
Zhao H, et al. Among authors: tang h.
Am J Cancer Res. 2016 Nov 1;6(11):2575-2586. eCollection 2016.
Am J Cancer Res. 2016.
PMID: 27904772
Free PMC article.